Deals and Data, Tim Ingersoll’s monthly waltz through the world of San Diego biotech, is making its rounds. Among the highlights in this month’s column is news from Amylin Pharmaceuticals and Arena Pharmaceuticals, two companies we wrote about Monday.
The Biocom spokesman also offers lots of other tidbits on everything from stock offerings to plant openings to drug successes and failures.